{"Title": "Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia\u2013real-world resource use data", "Year": 2020, "Source": "Leuk. Lymphoma", "Volume": "61", "Issue": 2, "Art.No": null, "PageStart": 491, "PageEnd": 493, "CitedBy": 0, "DOI": "10.1080/10428194.2019.1672057", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074026875&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-85074026875", "SubjectAreas": [["Hematology", "MEDI", "2720"], ["Oncology", "MEDI", "2730"], ["Cancer Research", "BIOC", "1306"]], "AuthorData": {"57211453909": {"Name": "Lecat C.S.Y.", "AuthorID": "57211453909", "AffiliationID": "60024544", "AffiliationName": "Department of Haematology, University College London Hospitals"}, "9941088900": {"Name": "Hough R.E.", "AuthorID": "9941088900", "AffiliationID": "60024544", "AffiliationName": "Department of Haematology, University College London Hospitals"}, "57191830711": {"Name": "Besley C.", "AuthorID": "57191830711", "AffiliationID": "60024764, 60170515", "AffiliationName": "Bristol Haematology & Oncology Centre, University Hospitals Bristol"}, "36769068100": {"Name": "Furness C.", "AuthorID": "36769068100", "AffiliationID": "60024764, 60170515", "AffiliationName": "Bristol Haematology & Oncology Centre, University Hospitals Bristol"}, "7202505808": {"Name": "Marks D.I.", "AuthorID": "7202505808", "AffiliationID": "60024764, 60170515", "AffiliationName": "Bristol Haematology & Oncology Centre, University Hospitals Bristol"}, "7005296444": {"Name": "Khwaja A.", "AuthorID": "7005296444", "AffiliationID": "60109234", "AffiliationName": "UCL Cancer Institute"}, "7102396522": {"Name": "Fielding A.K.", "AuthorID": "7102396522", "AffiliationID": "60109234", "AffiliationName": "UCL Cancer Institute"}}}